InvivoGen
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables them to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
More information at https://www.invivogen.com.
InvivoGen
Multigenic plasmid for high levels of expression of GFP and LacZ reporter genes in tumors
InvivoGen
Multigenic plasmid for high levels of expression of GFP and SEAP reporter genes in tumors
InvivoGen
Multigenic plasmid for high levels of expression of Lucia and SEAP reporter genes in tumors
InvivoGen
Multigenic plasmid for high levels of expression of GFP and LacZ reporter genes in vivo
InvivoGen
Multigenic plasmid for high levels of expression of GFP and SEAP reporter genes
InvivoGen
Multigenic plasmid for high levels of expression of Lucia and SEAP reporter genes
InvivoGen
Multigenic cloning plasmid for strong and sustained expression in normal tissues
InvivoGen
Assay for the detection and quantification of biologically active LPS
